Genetic variation of CYP2A6, smoking, and risk of cancer.
about
Genetic risk and behavioural changePolymorphisms of CYP2A6 and its practical consequencesNovel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer RiskGenomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive PhenotypeGenetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction.Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis.Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China.The genetics of nicotine dependence: relationship to pancreatic cancer.Candidate gene case-control association studies: advantages and potential pitfalls.Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.Tobacco use and cancer: an epidemiologic perspective for geneticists.Applying genetic approaches to the treatment of nicotine dependence.Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.Candidate gene case-control studies.Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokersPhenotypic CYP2A6 variation and the risk of pancreatic cancer.A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.Emerging genetics of COPD.Overview of the pharmacogenomics of cigarette smoking.Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancerPolymorphic metabolism by functional alterations of human cytochrome P450 enzymes.Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence.Inter-gene correlation on oligonucleotide arrays: how much does normalization matter?Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans.Association between CYP2A6 genetic polymorphisms and lung cancer: a meta-analysis of case-control studies.Determination of coumarin metabolism in Turkish population.Effects of whole deletion of CYP2A6 on nicotine metabolism in humans.Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6.CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives.Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.
P2860
Q24525204-B4F2F81A-3405-4F41-9AC8-BC87EA40B0B6Q28362536-7A7B87B1-93F1-428B-9011-F30348A43C16Q28390824-C6D02699-9BD2-43C6-882B-C39A820FCFFDQ28395447-C58CCA1A-C404-46BB-A540-594F30983D18Q30491854-5F57BAAF-3EB0-4984-9D6A-59A21786A142Q32160224-DFE237EA-0FE9-4C41-8608-6D20DE7FDD51Q33224655-01B0EC2E-B4F9-4988-9F2E-07894B250CA9Q33455775-9FCB74FD-DE11-4755-B553-FBA2CEB9D3C2Q33529216-04269626-47AC-43B3-AA62-AC371BC17F31Q33866866-92C88CB5-FB4A-4329-9175-2F75CCF3E7BBQ34459045-0D5C02F4-ED4F-48D8-87D1-EAB0A79A7D17Q34799785-20C83F99-268A-4066-AE12-BADF685CA79EQ34963451-6C134674-EA90-4767-908E-B87F6D4D7723Q34963561-1B7D7196-9513-4DB3-925D-47A5245FC4B1Q35027945-96F32491-4B19-4CA7-BFEE-90729D99155AQ35073279-9DBB649A-7DA3-4194-9647-EF7D9A5EE50CQ35173305-F08010F9-83BC-4565-A2FC-3427B485CB40Q35428436-DA3BE078-C9E7-4B5A-BAF4-AB1DF2A8BEA0Q35816887-2703401F-9515-492B-A5E9-6839EB408CA9Q35876954-50F196B6-C751-4547-BE93-93A7D963E95FQ36203479-FC53E173-53EC-41BF-B68B-F23FE7AFFD00Q36389310-902184AF-0932-4574-9D52-627B9B8E941FQ36708951-FB07BFC4-D7AB-412D-8E59-E274E449674FQ36989832-ADB2777A-60D5-4C68-8829-204284E04522Q37008114-048750FE-4DAF-47EE-BF5C-2090E4E320C9Q37296120-E7567682-B521-49D3-9EF6-731B67BDF573Q37964573-59923D30-EA2C-49EF-B958-D34DB08E1A70Q38683483-908BC806-500A-48E6-A8F5-F92EBB63C43DQ40741413-A6357DAD-093B-4045-AA0A-648581804EA9Q42664210-CA844DA3-3073-4CA5-89DD-60AB3DF9DD0DQ42994051-D01E34C3-C017-4E31-95A5-C43419764456Q43459056-6805D1B0-846B-41F6-9409-2A844CBB6BDCQ43580817-A2659E07-6D6A-45DC-B137-C2BF9A9D71D2Q43630476-1057CFA4-3A28-413C-B6B7-687E7FAC6EBAQ44002892-D368E57A-A647-40ED-978F-423D23958662Q44062521-1699E616-B43A-4E18-B2A7-096B3FEC5371Q45144875-B1679037-49C3-40F4-A5A7-64F682108A0AQ45234608-80978922-7D55-4763-923B-36B9F1F46715Q46420060-173FDEEB-5101-4920-8118-50D50EA24314Q46886466-9C321086-4DC5-45DC-BB5E-3F89D5E81101
P2860
Genetic variation of CYP2A6, smoking, and risk of cancer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Genetic variation of CYP2A6, smoking, and risk of cancer.
@en
Genetic variation of CYP2A6, smoking, and risk of cancer.
@nl
type
label
Genetic variation of CYP2A6, smoking, and risk of cancer.
@en
Genetic variation of CYP2A6, smoking, and risk of cancer.
@nl
prefLabel
Genetic variation of CYP2A6, smoking, and risk of cancer.
@en
Genetic variation of CYP2A6, smoking, and risk of cancer.
@nl
P50
P1433
P1476
Genetic variation of CYP2A6, smoking, and risk of cancer
@en
P2093
G A Coetzee
P304
P356
10.1016/S0140-6736(98)04984-8
P407
P577
1999-03-01T00:00:00Z